1,279 results on '"Riecher-Rössler, Anita"'
Search Results
2. Proteomic Biomarkers for the Prediction of Transition to Psychosis in Individuals at Clinical High Risk: A Multi-cohort Model Development Study.
3. Oestrogens and Mental Health
4. Brain texture as a marker of transdiagnostic clinical profiles in patients with recent-onset psychosis and depression
5. Editorial 1/24
6. Individualized pretest risk estimates to guide treatment decisions in patients with clinical high risk for psychotic disorders
7. Structural and Functional Brain Patterns Predict Formal Thought Disorder’s Severity and Its Persistence in Recent-Onset Psychosis: Results From the PRONIA Study
8. Serum immune markers and transition to psychosis in individuals at clinical high risk
9. Menopause and Mental Health
10. Neurobiologically Based Stratification of Recent-Onset Depression and Psychosis: Identification of Two Distinct Transdiagnostic Phenotypes
11. Machine learning based prediction and the influence of complement – Coagulation pathway proteins on clinical outcome: Results from the NEURAPRO trial
12. Verbal memory performance predicts remission and functional outcome in people at clinical high-risk for psychosis
13. Latent state-trait structure of BPRS subscales in clinical high-risk state and first episode psychosis
14. Evidence that complement and coagulation proteins are mediating the clinical response to omega-3 fatty acids: A mass spectrometry-based investigation in subjects at clinical high-risk for psychosis
15. The association of plasma inflammatory markers with omega-3 fatty acids and their mediating role in psychotic symptoms and functioning: An analysis of the NEURAPRO clinical trial
16. Vulnerability and Protective Factors for Mental Health: A Rereading in Gender Perspective
17. Distinct multimodal biological and functional profiles of symptom-based subgroups in recent-onset psychosis
18. Association between tobacco use and symptomatology in individuals at ultra-high risk to develop a psychosis: A longitudinal study
19. Relation between self-perceived stress, psychopathological symptoms and the stress hormone prolactin in emerging psychosis
20. Machine Learning for Large-Scale Quality Control of 3D Shape Models in Neuroimaging.
21. Cognitive functioning throughout adulthood and illness stages in individuals with psychotic disorders and their unaffected siblings
22. The association between migrant status and transition in an ultra-high risk for psychosis population
23. Supplementation with the omega-3 long chain polyunsaturated fatty acids: Changes in the concentrations of omega-3 index, fatty acids and molecular phospholipids of people at ultra high risk of developing psychosis
24. Comparison of erythrocyte omega-3 index, fatty acids and molecular phospholipid species in people at ultra-high risk of developing psychosis and healthy people
25. Editorial
26. Cognitive functioning in ultra-high risk for psychosis individuals with and without depression: Secondary analysis of findings from the NEURAPRO randomized clinical trial
27. Anatomical integrity within the inferior fronto-occipital fasciculus and semantic processing deficits in schizophrenia spectrum disorders
28. The NEURAPRO Biomarker Analysis: Long-Chain Omega-3 Fatty Acids Improve 6-Month and 12-Month Outcomes in Youths at Ultra-High Risk for Psychosis
29. Trajectories of symptom severity and functioning over a three-year period in a psychosis high-risk sample: A secondary analysis of the Neurapro trial
30. Individualized prediction of psychosis in subjects with an at-risk mental state
31. Predictors of study drop-out and service disengagement in patients at clinical high risk for psychosis
32. Editorial: Women and the Pandemic
33. Professional Conduct and Handling Misconduct in Psychotherapy: Ethical Practice between Boundaries, Relationships, and Reality
34. Clinical and functional long-term outcome of patients at clinical high risk (CHR) for psychosis without transition to psychosis: A systematic review
35. Neurocognition as a predictor of transition to psychotic disorder and functional outcomes in ultra-high risk participants: Findings from the NEURAPRO randomized clinical trial
36. Weibliche Rollen und psychische Gesundheit
37. Psychotropic Drugs and the Perinatal Period
38. The role of gender as a barrier to the professional development of psychiatrists
39. Cortical Brain Abnormalities in 4474 Individuals With Schizophrenia and 5098 Control Subjects via the Enhancing Neuro Imaging Genetics Through Meta Analysis (ENIGMA) Consortium
40. The relationship between negative symptoms and cognitive functioning in patients at clinical high risk for psychosis
41. Sexually dimorphic subcortical brain volumes in emerging psychosis
42. Clinical trajectories in the ultra-high risk for psychosis population
43. Sex and gender differences in schizophrenic psychoses—a critical review
44. EEG microstates as biomarker for psychosis in ultra-high-risk patients
45. Appropriateness of Care and Joint Decision-Making Strategies
46. Opening the Black Box of Cognitive-Behavioural Case Management in Clients with Ultra-High Risk for Psychosis
47. The heterogeneity of attenuated and brief limited psychotic symptoms: association of contents with age, sex, country, religion, comorbidities, and functioning
48. Sex differences in prolactin levels in emerging psychosis: Indication for enhanced stress reactivity in women
49. Duration of untreated psychosis/illness and brain volume changes in early psychosis
50. Alpha oscillations underlie working memory abnormalities in the psychosis high-risk state
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.